FATE
Fate Therapeutics, Inc.Data: 2026-10-27
Quick Stats
Oct 27, 202657.8
AI Score
STRONG BUY0.6
Volume Ratio
Nov 12, 2026
Next Earnings
15
+ve Days (30d)
13
-ve Days (30d)
FATE Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
FATE Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
FATE Options - Sort by Max open Interest (near term)
27th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Daily Out of Money Options - Sort by Max open Interest (near term)
27th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Daily In the Money Options - Sort by Max open Interest (near term)
27th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Most Active Options by Volume(near term)
27th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FATE Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
FATE Stock Summary
Last updated Oct 27, 2026
FATE is currently trading at $2.07, positioned above its 200-day moving average of $1.94, indicating a long-term uptrend. The stock has a 52-week range of $0.95 to $3.23.
Technical Analysis: The 50-day moving average stands at $2.31, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 44.092, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.136, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates FATE at 57.8/100 with a STRONG BUY recommendation.
FATE (Fate Therapeutics, Inc.) Indicators
Last updated Oct 27, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 44.092 |
| CMF (20) | -0.136 |
| ROC (10) | 3.5 |
| ADX (14) | 10.17 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.087 |
| AROONOSC (14) | -57.143 |
| WILLAMS %R (14) | -39.048 |
| MFI (14) | 35.967 |
FATE Candlestick Patterns
No validated candlestick patterns fired for FATE in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Fate Therapeutics, Inc. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
FATE Moving Averages Analysis
Fate Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 27, 2026
FATE (Fate Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Oct 27, 2026
| Days | MA |
|---|---|
| 10 | 2.0 |
| 20 | 2.11 |
| 30 | 2.22 |
| 50 | 2.31 |
| 100 | 2.41 |
| 200 | 1.94 |
FATE Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 246.2 million |
| Earnings/Share ($) | -1.02 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.0175 |
| EPS Estimate Next Year ($) | -0.9675 |
| WallStreet Target Price ($) | 5.74 |
| Most Recent Quarter |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.